Literature DB >> 6311911

Enzyme-linked immunosorbent assay for susceptibility to varicella.

Z Shehab, P A Brunell.   

Abstract

Nonspecific reactions to the membrane antigen of varicella-zoster virus were found by fluorescent antibody assay in the sera of three children susceptible to the virus; one of these children subsequently developed varicella. None of the three sera, however, contained antibody to varicella-zoster virus that was detectable by enzyme-linked immunosorbent assay (ELISA). Moreover, the results of the ELISA clearly distinguished immune from susceptible individuals. The negative range was established with sera obtained from 15 individuals prior to the onset of varicella, and the positive range was established with sera obtained from 75 healthy donors with a history of varicella. The results of the ELISA correlated well with those of the fluorescent antibody assay (r = +0.84). Heterologous reactions to herpes simplex virus were found in one of seven sera tested, and such reactions to cytomegalovirus were found in two of five sera. Heterologous reactions to Epstein-Barr virus were found in none of eight sera tested. ELISA is easy, sensitive, and reproducible and can be used for routine screening for susceptibility to varicella.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311911     DOI: 10.1093/infdis/148.3.472

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Authors:  S P Steinberg; A A Gershon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

2.  Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency.

Authors:  H B Niebur; C M Duff; G F Shear; D Nguyen; T K Alberdi; M J Dorsey; J W Sleasman
Journal:  Clin Exp Immunol       Date:  2015-07-07       Impact factor: 4.330

3.  Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus.

Authors:  M L Landry; S D Cohen; D R Mayo; C K Fong; W A Andiman
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus.

Authors:  F E Berkowitz; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group.

Authors:  N J Webb; M M Fitzpatrick; D A Hughes; T J Brocklebank; B A Judd; M A Lewis; R J Postlethwaite; P A Smith; G Corbitt
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

6.  Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine.

Authors:  A K Gong; S V Lipton; P A Brunell
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

7.  Comparison of three commercially available assays for detection of varicella-zoster virus antibody.

Authors:  T B Martins; T D Jaskowski; C Schroder; B Streeter; H R Hill
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

8.  Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus.

Authors:  P J Provost; P M Keller; F S Banker; B J Keech; H J Klein; R S Lowe; D H Morton; A H Phelps; W J McAleer; R W Ellis
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

10.  The age of infection with varicella-zoster virus in St Lucia, West Indies.

Authors:  G P Garnett; M J Cox; D A Bundy; J M Didier; J St Catharine
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.